COVID-19: Federal & Non-Federal Funding Opportunities

To facilitate COVID-19 research projects, the OVPR has formed a team to identify funding opportunities and other programs to support this work. These opportunities will be shared with the research community on an ongoing basis.

Last updated on September 22, 2020

Jump to: Federal Sources  Non-Federal Sources

Federal

SPONSOR PROGRAM FUNDING DEADLINE
Department of Defense (DoD)

DARPA

DARPA Broad Agency Announcements Not Limited Varies; 4/23/2020 for BTO
Department of Defense (DoD) COVID-19 National Response Team    
Department of Defense (DoD)

USAMRDC

Peer Reviewed Medical Research Program (PRMRP) Funding Opportunities for COVID-19 Research Vary with mechanism Various
Department of Energy (DoE)

Argonne National Laboratory

 

Expedited, Rapid Access Call for COVID-19 Research N/A Ongoing
Department of Health and Human Services (HHS)

BARDA

Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) Not limited 10/31/2020
Department of Health and Human Services (HHS)

BARDA

2019 Novel Coronavirus Medical Countermeasure Partnership Opportunities None specified White Papers may be submitted on any day during open periods up to the following deadlines: 4/30/2020, 7/31/2020, 10/31/2020
Department of Health and Human Services (HHS)

BARDA

DRIVe EZ-BAA   Application date: ongoing

Department of Health and Human Services (HHS)

CDC

Annual Estimates of Influenza Vaccine Effectiveness for Preventing Medically Attended Laboratory-Confirmed Influenza in the United States Vary with mechanism 7/16/2023
Department of State (DoS) COVID-19 Small Grants Program Maximum award amount: $100,000 9/30/2020

Department of State (DoS)

E/GP

Office of Global Partnerships: COVID-19 Private Sector Engagement & Partnership Fund Anticipated awards of $50,000 to $1,000,000 5/30/2021

Department of State (DoS)

U.S. Mission to India

COVID-19 Small Grants Program $100,000 9/30/2020
Food and Drug Administration (FDA)

OGD

PBPK Models of Oral Absorption to Simulate the Results of Bioequivalence Studies Not specified Not specified
National Institutes of Health (NIH)

AHRQ

Notice of Intent: New Funding Opportunity Announcement to Support Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19 Not specified None specified
National Institutes of Health (NIH)

NCATS

Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions and Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs   Applications accepted on a rolling basis through 11/10/2020
National Institutes of Health (NIH)

NCATS

Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Health Need Vary with mechanism 7/10/2021
National Institutes of Health (NIH)

NCATS

Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) Vary with mechanism 10/17/2020
National Institutes of Health (NIH)

NCATS

Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01 Clinical Trial Required) Budgets limited to $3,000,000 direct costs/year for up to three years 1/24/2021
National Institutes of Health (NIH)

NCCIH, NIA, NIAAA

 

Notice of Special Interest (NOSI): Availability of Administrative Supplements and Urgent Competitive Revisions for Research on Stress Management in Relation to Coronavirus Disease 2019 (COVID-19) Not specified Applications accepted on a rolling basis through 10/6/2020
National Institutes of Health (NIH)

NCI

Notice of Information: Contributing to the Global COVID-19 Crisis Response by Allowing Some NCI-supported Projects to be Redirected to COVID-19-related Research During the Crisis N/A -- allows existing resources to be redirected For the duration of the present crisis
National Institutes of Health (NIH)

NCI, NCCIH, NHGRI, NIAID, NICHD, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NIBIB, NCATS, NIAAA

Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement – Clinical Trial Optional) Up to level of parent award Applications accepted on an ongoing basis through 3/25/2021

National Institutes of Health (NIH)

NCI, NHGRI, NCCIH, NINDS, ORIP, NIMHD, NIA, NIDCR, NIAID, NIAMS, NIEHS, NCATS, NIDCD, NICHD, NIDDK, NHLBI

Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project Up to $1,000,000 in direct costs for one year projects. 7/13/2020, 11/12/2020, 3/12/2021, and 7/12/2021
National Institutes of Health (NIH)

NHLBI

(ROA): Host-targeting Therapies for COVID-19 No specific limit Applicants must first submit a Letter or Request. Stage 1 Letters of Request will be considered on a monthly bass starting (May 15, June 15, July 15, August 15).
National Institutes of Health (NIH)

NHLBI

Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) Up to level of parent award Applications accepted on a rolling basis through 5/15/2020

National Institutes of Health (NIH)

NIA

NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required) Budgets are not limited; projects of up to 5 years 7/1/2020; 8/3/2020; 9/1/2020; 10/1/2020; 11/2/2020; 12/1/2020; 1/4/2021; and 2/1/2021
National Institutes of Health (NIH)

NIAID
Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Select Research Activities related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Application budgets should not exceed the annual amount of the current parent award; projects should not exceed two years. Applications accepted on a rolling basis to 7/2/2021
National Institutes of Health (NIH)

NIAID

Administrative Supplement Not Limited 2/6/2020 (applications accepted through 2/6/2021)
National Institutes of Health (NIH)

NIAID

2020 NIAID Omnibus Broad Agency Announcement (BAA) Not Limited 6/30/2021
National Institutes of Health (NIH)

NIAID, NIGMS

Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV) Not limited 2/6/2020 (applications accepted through 4/8/2020)
National Institutes of Health (NIH)

NIA, NIAAA, NICHD, NIDA, NIMH, NINDS, NINR, NIMHD, NCCIH

Notice of Additional Due Date and Additional “Areas of Focus Especially of Interest” of PAR-19-373 and PAR-19-384, "Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01)" Not limited Application dates: 6/8/2020 and 3/17/2021
National Institutes of Health (NIH)

NIA, NIMH

 

Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) Not limited 5/1/2021
National Institutes of Health (NIH)

NIAAA

Notice of Special Interest: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA Limited to no more than $100,000 direct costs per year for two, unless special permission is granted 4/15/2021
National Institutes of Health (NIH)

NIAID, NIA

Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) Not limited 5/13/2020; 9/13/2020; and others
National Institutes of Health (NIH)

NIAID

Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed) Application budgets are not limited but need to reflect the actual needs of the proposed project. Applications accepted on a rolling basis through 7/8/2021
National Institutes of Health (NIH)

NIAID

Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Up to level of parent award 3/25/2021
National Institutes of Health (NIH)

NIAID

Partnerships for Countermeasures against Select Pathogens (R01 Clinical Trials Not Allowed) $4,050,000 6/29/2020
National Institutes of Health (NIH)

NIAID

Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trial Not Allowed) $275,000 (direct costs) 9/9/2020
National Institutes of Health (NIH)

NIAID

Notice of Special Interest (NOSI): Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2 Not limited but prior approval required for applicants requesting $500,000 or more in direct costs in any year 9/1/2021
National Institutes of Health (NIH)

NIBIB

Fast-Track Program for COVID-19 Test Development and Distribution Various packages of project development work.  

National Institutes of Health (NIH)

NICHD

Notice of Special Interest: Emerging Viral Infections and their Impact on the Male and Female Reproductive Tract Vary with mechanism 7/16/2023
National Institutes of Health (NIH)

NIDA

Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus $100K direct costs/yr 3/19/2020 (applications accepted through 3/31/2021)
National Institutes of Health (NIH)

NIDA

 

Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus No more than $100,000 unless strongly justified 3/31/2021
National Institutes of Health (NIH)

NIDCD

 

Notice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders Vary with mechanism Various application date on or after 10/5/2020
National Institutes of Health (NIH)

NIDCR

Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements for Coronavirus Disease 2019 (COVID-19) Research within the Mission of NIDCR Up to one year of support; requests should not exceed $150,000 in total direct costs without strong, compelling justification. Application dates: 6/1/2020 and 11/2/2020

National Institutes of Health (NIH)

NIDDK

Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional) Application budgets are limited to $250,000 in direct costs per year, for up to 3 years 12/16/2020
National Institutes of Health (NIH)

NIEHS

Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) Not specified 5/4/2021
National Institutes of Health (NIH)

NIGMS

Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 Must reflect your needs 3/5/2020 (applications accepted through 2/5/2021)
National Institutes of Health (NIH)

NIGMS

Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) Up to level of parent award 2/5/2021

National Institutes of Health (NIH)

NIMHD

Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional) Projects up to $500,000 direct costs annually, for 5 years. 8/28/2020; 12/1/2020

National Institutes of Health (NIH)

NIMH, NCCIH, SGMRO, ODP, NIDCD, OBSSR, NEI, NIDA, NIA, NIAAA, NICHD, NCATS, ORWH, NIDCR, NINR, NIMHD

Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional) Up to $750,000 direct costs per year, for 3 years 8/20/2020, 12/2/2020, 3/2/2021
National Institutes of Health (NIH)

NIMHD, NIA, NICHD, NIDCD, NIDCR, NIDA, NIEHS, NIMH, NINR, NCCIH

Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations Up to no more than $250,000 in direct costs per year Applications will be accepted on a rolling basis from 6/10/2020 through 12/15/2020
National Institutes of Health (NIH)

NIMHD, NIA, NIMH

Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities No more than $125,000 in direct costs 5/1/2021
National Institutes of Health (NIH)

NIMHD, NIA, NIDA, NCI

Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional) Budget not limited; projects up to 5 years Standard NIH application dates, first date is 10/5/2020
National Institutes of Health (NIH)

NIMH, NIA, NIAAA, NIMHD

Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus Not specified 4/15/2021

National Institutes of Health (NIH)

NIMH, NEI, NIA, NIAAA, NICHD, NIDCD, NIDCR, NIDDK, NIDA, NINR, NIMHD, NCCIH, NCATS

Notice of Special Interest (NOSI): Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 Budgets are limited to no more than $200,000 direct costs Applications will be accepted on a rolling basis through 12/15/2020
National Institutes of Health (NIH)

NINDS

Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System Budgets limited to $200,000 direct costs except in rare circumstances Applications accepted on a rolling basis through 4/14/2021
National Institutes of Health (NIH)

OBSSR, NIA, NIAAA, NIDDK, NIEHS, NCCIH, NCI, NICHD

Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences Limited to no more than $100,000 direct costs per year unless strongly justified Applications accepted on a rolling basis through 3/31/2021
National Institutes of Health (NIH)

OD

Notice of Intent to Publish Funding Opportunity Announcements for the RADx-UP Initiatives   First due dates expected to be in July
National Institutes of Health (NIH)

OD, NHLBI, NIAID, NIAMS, NICHD, NIDA, NIMHD, FIC, NCATS

Emergency Awards: RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds) (R61/R33 Clinical Trial Optional) Application budgets are limited to $500,000 in direct costs per year in the R61 phase and $1,000,000 in direct costs per year in the R33 phase. Applicants may request up to two years of support for the R61 phase, and up to two years of support for the R33 phase. 9/30/2020

National Institutes of Health (NIH)

OD, NHLBI, NIA, NIAAA, NICHD, NIDCD, NIDDK, NIDA, NIEHS, NIGMS, NINR, NIMHD, NLM, NCCIH

Emergency Awards: RADx-rad Data Coordination Center (DCC) (U24 Clinical Trial Not Allowed) Up to $4 million in annual direct costs for 4 years 9/30/2020

National Institutes of Health (NIH)

OD, NIAAA, NIDCR, NIDDK, NIDA, NIGMS, NINR, NIMHD, NLM

Emergency Awards: RADx-RAD Multimodal COVID-19 surveillance methods for high risk clustered populations (R01 Clinical Trial Optional) Budgets are not limited; projects of up to 3 years may be proposed 9/30/2020
National Institutes of Health (NIH)

OSC

NIH Director’s Emergency Transformative Research Awards (R01 Clinical Trial Optional) Budgets are not limited 9/30/2020
National Science Foundation (NSF) Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19)   Various
National Science Foundation (NSF) Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19)   Various

National Science Foundation (NSF)

BIO, ENG

Dear Colleague Letter: Sentinel Cells for Surveillance and Response to Emergent Infectious Diseases (Sentinels) Budgets not limited The relevant programs in BIO/MCB and ENG/CBET all accept proposals without deadline. Proposals are reviewed as they are received.
National Science Foundation (NSF)

IIP

Dear Colleague Letter: Request for SBIR/STTR Phase I Proposals Addressing COVID-19 Vary with mechanism 12/3/2020

U.S. Department of Agriculture (USDA)

NIFA

Agriculture and Food Research Initiative - Foundational and Applied Science Program Vary with grant type 7/29/2021
USG

PHEMCE

CoronaWatch: COVID-19 MEETING REQUEST FOCUS N/A  

Non-Federal

SPONSOR PROGRAM FUNDING DEADLINE
Amazon Web Services (AWS) AWS Diagnostic Development Initiative (DDI) Not specified ongoing
American Association of Orthodontists Foundation 2021 Award Proposals: Call for Proposals to Study COVID-19 Related Outcomes Award maximums vary with program 11/13/2020
Cisco Research Center (CRC) Pandemic/COVID19 Science, Technology and Social Impact Not specified Proposals are reviewed and funding decisions are made on a rolling basis.
COVID-19 Early Treatment Fund (CETF) COVID-19 Early Treatment Fund (CETF)   Continuous submission
COVID-19 HPC Consortium The COVID-19 High Performance Computing (HPC) Consortium Not specified None specified
Cystic Fibrosis Foundation SARS-CoV-2 and Cystic Fibrosis Research Award Up to $125,000 per year (plus 12% for indirect costs) for up to two years. Letter of Intent: 7/17/2020; Full application: 10/1/2020
Draper Richards Kaplan Foundation DRK COVID-19 Urgent Response Initiative (CURI) The foundation anticipates funding for most projects to be in the $50k-100k range. Continuous submission
Emergent Ventures Fast Funding for COVID-19 Science Up to $500,000 None specified
Encephalitis Society Encephalitis and Covid-19 - International Research Seed Funding Up to £10,000 for projects of no more than 18 months duration Proposals due by 8/31/2020
Ferring Pharmaceuticals Ferring COVID-19 Investigational Grants in Reproductive Medicine and Maternal Health EUR 25,000 10/31/2020
Gilead Sciences COVID-19 RFP Program: COMMIT™
(COvid-19 unMet MedIcal needs and associated research exTension)
Up to $250,000 Letters of intent accepted through to 8/3/2020
Google COVID-19 Research Grants Not specified None specified
Hopkins Population Center (HPC) HPC Call for Lightning Pilot Applications to Population-Based Studies of COVID-19 $5,000 - $10,000 Rolling basis, reviews start 3/27/2020
The Jacob and Valeria Langeloth Foundation COVID-19 Rapid Response Fund (CRRF) Not specified Continuous submission
Mozilla.org COVID-19 Solutions Fund Up to $50,000 Applications accepted on a rolling basis
Novartis US Foundation Novartis COVID-19 Community Response Fund $100,000 to $250,000 None specified
Omidyar Network India Rapid Response Funding for COVID-19 Up to Rs. 2 crore (approx. $250,000) Ongoing
Patient-Centered Outcomes Research Institute (PCORI) PCORI Funding Opportunity for COVID-19-Related Enhancements to Existing PCORI-Funded Research Projects $500,000 limit (direct and indirect costs)—higher amounts will be considered on a case-by-case basis On a rolling basis
Patient-Centered Outcomes Research Institute (PCORI) PCORI Funding Opportunity for COVID-19-Related Enhancements to Existing PCORI-Funded Engagement Awards Up to $150,000 (direct and indirect costs) Proposals considered on a rolling basis
Patient-Centered Outcomes Research Institute (PCORI) PCORI Funding Opportunity for COVID-19-Related Enhancements to Existing PCORI-Funded Dissemination and Implementation Awards $500,000 limit (direct and indirect costs)—higher amounts will be considered on a case-by-case basis Proposals considered on a rolling basis
Patient-Centered Outcomes Research Institute (PCORI) Phased Large Awards for Comparative Effectiveness Research – Cycle 3 2020 Investigators may request up to $2 million in direct costs for a feasibility phase up to 18 months in duration, with up to $20 million in direct costs for continuation to a full-scale study phase up to five years in duration. Letter of Intent (LOI) Deadline: 9/29/2020; Full applications will be due Tuesday, 1/12/2021
Robert Wood Johnson Foundation Pioneering Ideas: Exploring the Future to Build a Culture of Health The average Pioneer grant in 2019 was $315,031. However, there is not an explicit range for budget requests. Grant periods are flexible, though generally range from 1 to 3 years. Open
TD Bank 2020 TD Ready Challenge One-time grants ranging from $350,000 CAD to $1 million CAD each (approximate equivalent of $260,000 USD to $745,000 USD)  
XPRIZE XPRIZE Next-Gen Mask Challenge Up to $500,000 10/22/2020